Standardising CAR T-Cell Monitoring to Improve Clinical Insights & Translational Outcomes
- Highlight approaches to monitor CAR T-cells consistently during production and in patients
- Explore how monitoring informs therapy development, safety, and efficacy assessments
- Discuss the potential for standardised monitoring to guide clinical decisions and improve outcomes